Skip to main content
. 2022 Jan 15;14(1):55–74. doi: 10.4251/wjgo.v14.i1.55

Table 6.

Association with Helicobacter pylori infection and gastrointestinal tract lymphoma


Prevalence of H. pylori
Diagnostic tool for H. pylori
Study design
P value
Parsonnet et al[95] (Gastric NHL) OR: 6.3; 95%CI: 2.0-19.9 Serology Case- control study NA
Ishikura et al[97] (Gastric lymphoma overall) OR: 2.14; 95%CI: 1.3-3.5 Serology Case- control study P = 0.003
Ishikura et al[97] (Gastric MALT) OR: 1.96; 95%CI: 1.0-3.9 Serology Case- control study P = 0.051
Ishikura et al[97] (Gastric DLBCL) OR: 1.92; 95%CI: 0.74-4.95 Serology Case- control study P = 0.178
Parsonnet et al[95] (Non-gastric NHL) OR: 1.2; 95%CI: 0.5-3.0 Serology Case- control study NA

NHL: Non-Hodgkin’s lymphomas; MALT: Mucosa-associated lymphoid tissue; DLBCL: Diffuse large B-cell lymphoma; OR: Odds ratio; CI: Confidence interval; H. pylori: Helicobacter pylori; NA: Not available.